{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:36:41Z","timestamp":1767706601146},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Gerontol Geriat"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00391-011-0261-7","type":"journal-article","created":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T00:48:52Z","timestamp":1327538932000},"page":"23-33","source":"Crossref","is-referenced-by-count":3,"title":["Co-occurrence of parkinsonism and dementia in clinical practice"],"prefix":"10.1007","volume":"45","author":[{"given":"I.","family":"Liepelt-Scarfone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Jamour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Maetzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,27]]},"reference":[{"key":"261_CR1","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1007\/s11064-010-0346-5","volume":"35","author":"Battistin","year":"2010","unstructured":"Battistin L, Cagnin A (2010) Vascular cognitive disorder. A biological and clinical overview. Neurochem Res 35:1933\u20131938","journal-title":"Neurochem Res"},{"key":"261_CR2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00415-005-0971-0","volume":"253","author":"Bohnen","year":"2006","unstructured":"Bohnen NI, Kaufer DI, Hendrickson R et al (2006) Cognitive correlates of cortical cholinergic denervation in Parkinson\u2019s disease and parkinsonian dementia. J Neurol 253:242\u2013247","journal-title":"J Neurol"},{"key":"261_CR3","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/jnnp.2006.108076","volume":"78","author":"Bronnick","year":"2007","unstructured":"Bronnick K, Emre M, Lane R et al (2007) Profile of cognitive impairment in dementia associated with Parkinson\u2019s disease compared with Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 78:1064\u20131068","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"261_CR4","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","volume":"134","author":"Compta","year":"2011","unstructured":"Compta Y, Parkkinen L, O\u2019Sullivan SS et al (2011) Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important? Brain 134:1493\u20131505","journal-title":"Brain"},{"key":"261_CR5","first-page":"147","volume":"82","author":"Cummings","year":"2000","unstructured":"Cummings J, Litvan I (2000) Neuropsychiatric aspects of corticobasal degeneration. Adv Neurol 82:147\u2013152","journal-title":"Adv Neurol"},{"key":"261_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0895-4356(01)00425-5","volume":"55","author":"Elbaz","year":"2002","unstructured":"Elbaz A, Bower JH, Maraganore DM et al (2002) Risk tables for parkinsonism and Parkinson\u2019s disease. J Clin Epidemiol 55:25\u201331","journal-title":"J Clin Epidemiol"},{"key":"261_CR7","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0140-6736(02)08267-3","volume":"359","author":"Erkinjuntti","year":"2002","unstructured":"Erkinjuntti T, Kurz A, Gauthier S et al (2002) Efficacy of galantamine in probable vascular dementia and Alzheimer\u2019s disease combined with cerebrovascular disease: a randomised trial. Lancet 359:1283\u20131290","journal-title":"Lancet"},{"key":"261_CR8","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/WNL.0b013e3181f61311","volume":"75","author":"Forsaa","year":"2010","unstructured":"Forsaa EB, Larsen JP, Wentzel-Larsen T et al (2010) What predicts mortality in Parkinson disease? A prospective population-based long-term study. Neurology 75:1270\u20131276","journal-title":"Neurology"},{"key":"261_CR9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/mds.20535","volume":"20","author":"Geser","year":"2005","unstructured":"Geser F, Wenning GK, Poewe W et al (2005) How to diagnose dementia with Lewy bodies: state of the art. Mov Disord 20(Suppl 12):11\u201320","journal-title":"Mov Disord"},{"key":"261_CR10","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1212\/WNL.0b013e3181dc1a55","volume":"74","author":"Gilman","year":"2010","unstructured":"Gilman S, Koeppe RA, Nan B et al (2010) Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes. Neurology 74:1416\u20131423","journal-title":"Neurology"},{"key":"261_CR11","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1212\/WNL.53.9.1969","volume":"53","author":"Grimes","year":"1999","unstructured":"Grimes DA, Lang AE, Bergeron CB (1999) Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 53:1969\u20131974","journal-title":"Neurology"},{"key":"261_CR12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.22015","volume":"68","author":"Hamilton","year":"2010","unstructured":"Hamilton R, Patel S, Lee EB et al (2010) Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Ann Neurol 68:535\u2013540","journal-title":"Ann Neurol"},{"key":"261_CR13","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1136\/jnnp.51.6.850","volume":"51","author":"Hardie","year":"1988","unstructured":"Hardie RJ, Lees AJ (1988) Neuroleptic-induced Parkinson\u2019s syndrome: clinical features and results of treatment with levodopa. J Neurol Neurosurg Psychiatry 51:850\u2013854","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"261_CR14","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","volume":"9","author":"Kehagia","year":"2010","unstructured":"Kehagia AA, Barker RA, Robbins TW (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson\u2019s disease. Lancet Neurol 9:1200\u20131213","journal-title":"Lancet Neurol"},{"key":"261_CR15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/mds.21917","volume":"23","author":"Kuo","year":"2008","unstructured":"Kuo SH, Kenney C, Jankovic J (2008) Bilateral pedunculopontine nuclei strokes presenting as freezing of gait. Mov Disord 23:616\u2013619","journal-title":"Mov Disord"},{"key":"261_CR16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jalz.2009.04.1231","volume":"6","author":"Liepelt","year":"2010","unstructured":"Liepelt I, Gaenslen A, Godau J et al (2010) Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: clinical observations as a basis for power calculations and safety analysis. Alzheimers Dement 6:70\u201374","journal-title":"Alzheimers Dement"},{"key":"261_CR17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000101337","volume":"23","author":"Liepelt","year":"2007","unstructured":"Liepelt I, Maetzler W, Blaicher HP et al (2007) Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors. Dement Geriatr Cogn Disord 23:351\u2013367","journal-title":"Dement Geriatr Cogn Disord"},{"key":"261_CR18","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/mds.22662","volume":"24","author":"Liepelt","year":"2009","unstructured":"Liepelt I, Reimold M, Maetzler W et al (2009) Cortical hypometabolism assessed by a metabolic ratio in Parkinson\u2019s disease primarily reflects cognitive deterioration-[(18)F]FDG-PET. Mov Disord 24:1504\u20131511","journal-title":"Mov Disord"},{"key":"261_CR19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000256715.13907.d3","volume":"68","author":"Lippa","year":"2007","unstructured":"Lippa CF, Duda JE, Grossman M et al (2007) DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68:812\u2013819","journal-title":"Neurology"},{"key":"261_CR20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1212\/WNL.57.3.467","volume":"57","author":"Litvan","year":"2001","unstructured":"Litvan I, Phipps M, Pharr VL et al (2001) Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy. Neurology 57:467\u2013473","journal-title":"Neurology"},{"key":"261_CR21","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S1474-4422(09)70291-1","volume":"8","author":"Maetzler","year":"2009","unstructured":"Maetzler W, Liepelt I, Berg D (2009) Progression of Parkinson\u2019s disease in the clinical phase: potential markers. Lancet Neurol 8:1158\u20131171","journal-title":"Lancet Neurol"},{"key":"261_CR22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2008.12.008","volume":"34","author":"Maetzler","year":"2009","unstructured":"Maetzler W, Liepelt I, Reimold M et al (2009) Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics. Neurobiol Dis 34:107\u2013112","journal-title":"Neurobiol Dis"},{"key":"261_CR23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1212\/01.wnl.0000250230.86581.ea","volume":"68","author":"Maetzler","year":"2007","unstructured":"Maetzler W, Nagele T, Gasser T et al (2007) Acute parkinsonism with corresponding lesions in the basal ganglia after heroin abuse. Neurology 68:414","journal-title":"Neurology"},{"key":"261_CR24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3233\/JAD-2010-1289","volume":"19","author":"Maetzler","year":"2010","unstructured":"Maetzler W, Schmid B, Synofzik M et al (2010) The CST3 BB genotype and low cystatin C cerebrospinal fluid levels are associated with dementia in Lewy body disease. J Alzheimers Dis 19:937\u2013942","journal-title":"J Alzheimers Dis"},{"key":"261_CR25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3233\/JAD-2010-101197","volume":"22","author":"Maetzler","year":"2010","unstructured":"Maetzler W, Stoycheva V, Schmid B et al (2010) Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-beta42 levels in Lewy body disease. J Alzheimers Dis 22:933\u2013938","journal-title":"J Alzheimers Dis"},{"key":"261_CR26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","volume":"3","author":"McKeith","year":"2004","unstructured":"McKeith I, Mintzer J, Aarsland D et al (2004) Dementia with Lewy bodies. Lancet Neurol 3:19\u201328","journal-title":"Lancet Neurol"},{"key":"261_CR27","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology 65:1863\u20131872","journal-title":"Neurology"},{"key":"261_CR28","first-page":"964","volume":"117","author":"Mummenthaler","year":"1987","unstructured":"Mummenthaler M (1987) Behebbare und vermeidbare Demenzen. Schweiz Med Wochenschr 117:964\u2013967","journal-title":"Schweiz Med Wochenschr"},{"key":"261_CR29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00391-010-0125-6","volume":"43","author":"Nicolai","year":"2010","unstructured":"Nicolai S, Mirelman A, Herman T et al (2010) Improvement of balance after audio-biofeedback. A 6-week intervention study in patients with progressive supranuclear palsy. Z Gerontol Geriatr 43:224\u2013228","journal-title":"Z Gerontol Geriatr"},{"key":"261_CR30","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/brain\/awn065","volume":"131","author":"O","year":"2008","unstructured":"O\u2019Sullivan SS, Massey LA, Williams DR et al (2008) Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 131:1362\u20131372","journal-title":"Brain"},{"key":"261_CR31","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/bmj.310.6985.970","volume":"J","author":"Ott","year":"1995","unstructured":"Ott A, Breteler MM, Van Harskamp F et al (1995) Prevalence of Alzheimer\u2019s disease and vascular dementia: association with education. The Rotterdam study. Br Med J (Clin Res) 10:970\u2013973","journal-title":"Br Med"},{"key":"261_CR32","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/STROKEAHA.110.579888","volume":"41","author":"Pendlebury","year":"2010","unstructured":"Pendlebury ST, Cuthbertson FC, Welch SJ et al (2010) Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke 41:1290\u20131293","journal-title":"Stroke"},{"key":"261_CR33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000218198","volume":"45","author":"Penn","year":"2009","unstructured":"Penn RD, Linninger A (2009) The physics of hydrocephalus. Pediatr Neurosurg 45:161\u2013174","journal-title":"Pediatr Neurosurg"},{"key":"261_CR34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/STROKEAHA.108.530212","volume":"40","author":"Saczynski","year":"2009","unstructured":"Saczynski JS, Sigurdsson S, Jonsdottir MK et al (2009) Cerebral infarcts and cognitive performance: importance of location and number of infarcts. Stroke 40:677\u2013682","journal-title":"Stroke"},{"key":"261_CR35","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","volume":"69","author":"Schneider","year":"2007","unstructured":"Schneider JA, Arvanitakis Z, Bang W et al (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69:2197\u20132204","journal-title":"Neurology"},{"key":"261_CR36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2011.02.015","volume":"304","author":"Seijo-Martinez","year":"2011","unstructured":"Seijo-Martinez M, Castro Del Rio M, Rodriguez Alvarez J et al (2011) Prevalence of parkinsonism and Parkinson\u2019s disease in the Arosa Island (Spain): a community-based door-to-door survey. J Neurol Sci 304:49\u201354","journal-title":"J Neurol Sci"},{"key":"261_CR37","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/mds.22558","volume":"24","author":"Shelley","year":"2009","unstructured":"Shelley BP, Hodges JR, Kipps CM et al (2009) Is the pathology of corticobasal syndrome predictable in life? Mov Disord 24:1593\u20131599","journal-title":"Mov Disord"},{"key":"261_CR38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.archger.2004.04.049","volume":"9","author":"Sinforiani","year":"2004","unstructured":"Sinforiani E, Banchieri L, Zucchella C et al (2004) Cognitive rehabilitation in Parkinson\u2019s disease. Arch Gerontol Geriatr 9(Suppl):387\u2013391","journal-title":"Arch Gerontol Geriatr"},{"key":"261_CR39","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00702-010-0563-8","volume":"118","author":"Srulijes","year":"2011","unstructured":"Srulijes K, Mallien G, Bauer S et al (2011) In vivo comparison of Richardson\u2019s syndrome and progressive supranuclear palsy-parkinsonism. J Neural Transm 118:1191\u20131197","journal-title":"J Neural Transm"},{"key":"261_CR40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3171\/2011.2.JNS101316","volume":"115","author":"Tarnaris","year":"2011","unstructured":"Tarnaris A, Toma AK, Chapman MD et al (2011) Use of cerebrospinal fluid amyloid-beta and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus. J Neurosurg 115:145\u2013150","journal-title":"J Neurosurg"},{"key":"261_CR41","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archneur.1995.00540340109020","volume":"52","author":"Trenkwalder","year":"1995","unstructured":"Trenkwalder C, Schwarz J, Gebhard J et al (1995) Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly. Prevalence of Parkinson\u2019s disease and related disorders assessed by a door-to-door survey of inhabitants older than 65\u00a0years. Arch Neurol 52:1017\u20131022","journal-title":"Arch Neurol"},{"key":"261_CR42","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archneurol.2009.110","volume":"66","author":"Turner","year":"2009","unstructured":"Turner ST, Fornage M, Jack CR et al (2009) Genomic susceptibility Loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibships. Arch Neurol 66:847\u2013857","journal-title":"Arch Neurol"},{"key":"261_CR43","doi-asserted-by":"crossref","unstructured":"Villarejo A, Benito-Leon J, Trincado R et al (2011) Dementia-associated mortality at thirteen years in the NEDICES cohort study. J Alzheimers Dis (in press)","DOI":"10.3233\/JAD-2011-110443"},{"key":"261_CR44","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.23713","volume":"26","author":"Wenning","year":"2011","unstructured":"Wenning GK, Litvan I, Tolosa E (2011) Milestones in atypical and secondary parkinsonisms. Mov Disord 26:1083\u20131095","journal-title":"Mov Disord"},{"key":"261_CR45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","volume":"8","author":"Williams","year":"2009","unstructured":"Williams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 8:270\u2013279","journal-title":"Lancet Neurol"}],"container-title":["Zeitschrift f\u00fcr Gerontologie und Geriatrie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-011-0261-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00391-011-0261-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-011-0261-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T23:05:09Z","timestamp":1561244709000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00391-011-0261-7"}},"subtitle":["Relevant differential diagnoses"],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["261"],"URL":"https:\/\/doi.org\/10.1007\/s00391-011-0261-7","relation":{},"ISSN":["0948-6704","1435-1269"],"issn-type":[{"value":"0948-6704","type":"print"},{"value":"1435-1269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}